Skip to main content

Table 1 Epidemiology of S.aureus endocarditis

From: Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: Looking for a relationship between tolerance and outcome

Year

Total

DE (%)

NVE (%)

PVE (%)

PM

MRSA (%)

HA (%)

SUR (%)

EMB (%)

Cured (%)

≤2000

4

4

3

1

0

0

0

2

4

3

2001

3

3

3

0

0

1

2

3

2

3

2002

1

1

1

0

0

0

0

0

1

1

2003

1

1

1

0

0

1

1

0

1

0

2004

5

5

4

1

2

0

1

2

1

4

2005

14

14

12

2

0

2

5

5

9

11

2006

12

11

9

3

1

3

7

6

10

10

2007

3

3

2

1

0

0

1

0

2

0

2008

5

4

2

3

0

2

2

1

2

4

2009

14

11

10

4

0

4

4

1

8

9

Total

62

57 (91.9)

47 (75.8)

15 (24.2)

3

13 (21.0)

23 (37.0)

20 (32.3)

40 (64.5)

45 (72.6)

  1. DE (definite endocarditis, NVE (native valve endocarditis), PVE (prosthetic valve endocarditis), PM (pace maker), HA (hospital acquired), SUR (surgery), EMB (embolism)